SCHEMBL22508902

SCHEMBL22508902

Clc1ncnc2c1ccn2I

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.44
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
FGFR1 P11362 2/20 0.38
FGFR4 P22455 2/20 0.38
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
HTT P42858 1/20 0.32
PAX8 Q06710 1/20 0.32
TLR9 Q9NR96 1/20 0.32
SRC P12931 1/20 0.32
MEN1 O00255 1/20 0.31
NR2F2 P24468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18499505 0.77 SLC22A12 (0.42) SLC22A12PDE4APDE4BPDE4CPDE4D
SCHEMBL20417744 0.76 PI4KA (0.43) FGFR1PRMT5WDR77ALDH1A1MEN1
SCHEMBL1092832 0.76 SLC22A12 (0.44) SLC22A12PDE4APDE4BPDE4CPDE4D
SCHEMBL19465328 0.76 SLC22A12 (0.44) SLC22A12PDE4APDE4BPDE4CPDE4D
SCHEMBL29407694 0.76 NOTUM (0.46) SLC22A12PDE4APDE4BPDE4CPDE4D
SCHEMBL130757 0.76 NOTUM (0.46) SLC22A12PDE4APDE4BPDE4CPDE4D
SCHEMBL18572036 0.76 SLC22A12 (0.48) SLC22A12PDE4APDE4BPDE4CPDE4D
SCHEMBL16769961 0.76 SLC22A12 (0.41) SLC22A12PDE4APDE4BPDE4CPDE4D
SCHEMBL16254748 0.73 SLC22A12 (0.42) SLC22A12PDE4APDE4BPDE4CPDE4D
SCHEMBL22667781 0.73 SLC22A12 (0.42) SLC22A12PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020206308-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 PRELUDE THERAPEUTICS, INCORPORATED (US) 2020-10-08 WO disclosed